| Style | Citing Format |
|---|---|
| MLA | Rezazadeh A, Taghizadehghehi M. "Comment on “Retrospective Study of Hypersensitivity Reactions to Chemotherapeutic Agents in a Thoracic Oncology Service”." Journal of Clinical Pharmacy and Therapeutics, vol. 44, no. 2, 2019, pp. 335-336. |
| APA | Rezazadeh A, Taghizadehghehi M (2019). Comment on “Retrospective Study of Hypersensitivity Reactions to Chemotherapeutic Agents in a Thoracic Oncology Service”. Journal of Clinical Pharmacy and Therapeutics, 44(2), 335-336. |
| Chicago | Rezazadeh A, Taghizadehghehi M. "Comment on “Retrospective Study of Hypersensitivity Reactions to Chemotherapeutic Agents in a Thoracic Oncology Service”." Journal of Clinical Pharmacy and Therapeutics 44, no. 2 (2019): 335-336. |
| Harvard | Rezazadeh A, Taghizadehghehi M (2019) 'Comment on “Retrospective Study of Hypersensitivity Reactions to Chemotherapeutic Agents in a Thoracic Oncology Service”', Journal of Clinical Pharmacy and Therapeutics, 44(2), pp. 335-336. |
| Vancouver | Rezazadeh A, Taghizadehghehi M. Comment on “Retrospective Study of Hypersensitivity Reactions to Chemotherapeutic Agents in a Thoracic Oncology Service”. Journal of Clinical Pharmacy and Therapeutics. 2019;44(2):335-336. |
| BibTex | @article{ author = {Rezazadeh A and Taghizadehghehi M}, title = {Comment on “Retrospective Study of Hypersensitivity Reactions to Chemotherapeutic Agents in a Thoracic Oncology Service”}, journal = {Journal of Clinical Pharmacy and Therapeutics}, volume = {44}, number = {2}, pages = {335-336}, year = {2019} } |
| RIS | TY - JOUR AU - Rezazadeh A AU - Taghizadehghehi M TI - Comment on “Retrospective Study of Hypersensitivity Reactions to Chemotherapeutic Agents in a Thoracic Oncology Service” JO - Journal of Clinical Pharmacy and Therapeutics VL - 44 IS - 2 SP - 335 EP - 336 PY - 2019 ER - |